Related Experiment Video
Updated: Jul 29, 2026
09:13
Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
P2X1 stimulation promotes thrombin receptor-mediated platelet aggregation
J A Erhardt1, J R Toomey, S A Douglas
1GlaxoSmithKline, Department of Vascular Biology, King of Prussia, PA 19406, USA. joseph_a_erhardt@gsk.com
Journal of Thrombosis and Haemostasis : JTH
|April 26, 2006
Summary
Platelet P2X1 receptors amplify aggregation responses to low thrombin receptor stimulation. This interaction, involving ADP release, is crucial for platelet activation and thrombus formation.
Area of Science:
- Hematology
- Molecular Biology
- Cardiovascular Research
Background:
- P2X1 receptors are ATP-gated ion channels involved in platelet function.
- In vitro studies of P2X1 receptors are challenging due to rapid desensitization.
- Understanding P2X1 receptor roles in platelet activation is critical for thrombosis research.
Purpose of the Study:
- To investigate the role of P2X1 receptors in platelet activation, particularly their interaction with thrombin receptor stimulation.
- To elucidate the mechanisms underlying P2X1 receptor-mediated potentiation of platelet aggregation.
- To assess the impact of P2X1 receptor function on thrombus formation in vivo.
Main Methods:
- Utilized methods to preserve P2X1 receptor functionality for in vitro studies.
- Employed P2X1-deficient murine platelets and wild-type platelets with P2X1 inhibition.
- Investigated human platelet aggregation using PAR1 agonists and P2X1 antagonist MRS2159.
- Assessed the role of ADP in P2X1-mediated platelet priming.
Main Results:
- P2X1 deficiency or inhibition reduced aggregation initiated by low levels of PAR4 agonist in murine platelets.
- P2X1 antagonist MRS2159 inhibited aggregation to low PAR1 stimulation in human platelets.
- P2X1 receptor stimulation primed human platelets, converting sub-threshold PAR1 responses into significant aggregation.
- ADP receptor inhibition attenuated P2X1-mediated priming, indicating a role for ADP release.
Conclusions:
- Platelet P2X1 receptors play a novel, amplifying role in response to low-level thrombin receptor stimulation.
- The synergy between P2X1 and thrombin receptors involves enhanced ADP release.
- P2X1 receptors are important modulators of platelet aggregation and potential targets in thrombosis.
Related Concept Videos
01:15Amplifying Signals via Second Messengers
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
01:09GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
01:11IP3/DAG Signaling Pathway
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
01:17Intracellular Signaling Affects Focal Adhesions
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
01:22Formation of the Platelet Plug
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.